226 related articles for article (PubMed ID: 23193118)
1. Association of type 2 diabetes susceptibility variants with advanced prostate cancer risk in the Breast and Prostate Cancer Cohort Consortium.
Machiela MJ; Lindström S; Allen NE; Haiman CA; Albanes D; Barricarte A; Berndt SI; Bueno-de-Mesquita HB; Chanock S; Gaziano JM; Gapstur SM; Giovannucci E; Henderson BE; Jacobs EJ; Kolonel LN; Krogh V; Ma J; Stampfer MJ; Stevens VL; Stram DO; Tjønneland A; Travis R; Willett WC; Hunter DJ; Le Marchand L; Kraft P
Am J Epidemiol; 2012 Dec; 176(12):1121-9. PubMed ID: 23193118
[TBL] [Abstract][Full Text] [Related]
2. HNF1B and JAZF1 genes, diabetes, and prostate cancer risk.
Stevens VL; Ahn J; Sun J; Jacobs EJ; Moore SC; Patel AV; Berndt SI; Albanes D; Hayes RB
Prostate; 2010 May; 70(6):601-7. PubMed ID: 19998368
[TBL] [Abstract][Full Text] [Related]
3. Genetic susceptibility to type 2 diabetes is associated with reduced prostate cancer risk.
Pierce BL; Ahsan H
Hum Hered; 2010; 69(3):193-201. PubMed ID: 20203524
[TBL] [Abstract][Full Text] [Related]
4. Shared common variants in prostate cancer and blood lipids.
Andreassen OA; Zuber V; Thompson WK; Schork AJ; Bettella F; ; ; Djurovic S; Desikan RS; Mills IG; Dale AM
Int J Epidemiol; 2014 Aug; 43(4):1205-14. PubMed ID: 24786909
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide association study identifies a common variant associated with risk of endometrial cancer.
Spurdle AB; Thompson DJ; Ahmed S; Ferguson K; Healey CS; O'Mara T; Walker LC; Montgomery SB; Dermitzakis ET; ; Fahey P; Montgomery GW; Webb PM; Fasching PA; Beckmann MW; Ekici AB; Hein A; Lambrechts D; Coenegrachts L; Vergote I; Amant F; Salvesen HB; Trovik J; Njolstad TS; Helland H; Scott RJ; Ashton K; Proietto T; Otton G; ; Tomlinson I; Gorman M; Howarth K; Hodgson S; Garcia-Closas M; Wentzensen N; Yang H; Chanock S; Hall P; Czene K; Liu J; Li J; Shu XO; Zheng W; Long J; Xiang YB; Shah M; Morrison J; Michailidou K; Pharoah PD; Dunning AM; Easton DF
Nat Genet; 2011 May; 43(5):451-4. PubMed ID: 21499250
[TBL] [Abstract][Full Text] [Related]
6. TCF7L2 type 2 diabetes risk variant, lifestyle factors, and incidence of prostate cancer.
Drake I; Wallström P; Hindy G; Ericson U; Gullberg B; Bjartell A; Sonestedt E; Orho-Melander M; Wirfält E
Prostate; 2014 Sep; 74(12):1161-70. PubMed ID: 24961829
[TBL] [Abstract][Full Text] [Related]
7. Prostate cancer (PCa) risk variants and risk of fatal PCa in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
Shui IM; Lindström S; Kibel AS; Berndt SI; Campa D; Gerke T; Penney KL; Albanes D; Berg C; Bueno-de-Mesquita HB; Chanock S; Crawford ED; Diver WR; Gapstur SM; Gaziano JM; Giles GG; Henderson B; Hoover R; Johansson M; Le Marchand L; Ma J; Navarro C; Overvad K; Schumacher FR; Severi G; Siddiq A; Stampfer M; Stevens VL; Travis RC; Trichopoulos D; Vineis P; Mucci LA; Yeager M; Giovannucci E; Kraft P
Eur Urol; 2014 Jun; 65(6):1069-75. PubMed ID: 24411283
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of association of HNF1B variants with diverse cancers: collaborative analysis of data from 19 genome-wide association studies.
Elliott KS; Zeggini E; McCarthy MI; Gudmundsson J; Sulem P; Stacey SN; Thorlacius S; Amundadottir L; Grönberg H; Xu J; Gaborieau V; Eeles RA; Neal DE; Donovan JL; Hamdy FC; Muir K; Hwang SJ; Spitz MR; Zanke B; Carvajal-Carmona L; Brown KM; ; Hayward NK; Macgregor S; Tomlinson IP; Lemire M; Amos CI; Murabito JM; Isaacs WB; Easton DF; Brennan P; ; Barkardottir RB; Gudbjartsson DF; Rafnar T; Hunter DJ; Chanock SJ; Stefansson K; Ioannidis JP
PLoS One; 2010 May; 5(5):e10858. PubMed ID: 20526366
[TBL] [Abstract][Full Text] [Related]
9. Large-scale fine mapping of the HNF1B locus and prostate cancer risk.
Berndt SI; Sampson J; Yeager M; Jacobs KB; Wang Z; Hutchinson A; Chung C; Orr N; Wacholder S; Chatterjee N; Yu K; Kraft P; Feigelson HS; Thun MJ; Diver WR; Albanes D; Virtamo J; Weinstein S; Schumacher FR; Cancel-Tassin G; Cussenot O; Valeri A; Andriole GL; Crawford ED; Haiman C; Henderson B; Kolonel L; Le Marchand L; Siddiq A; Riboli E; Travis RC; Kaaks R; Isaacs W; Isaacs S; Wiley KE; Gronberg H; Wiklund F; Stattin P; Xu J; Zheng SL; Sun J; Vatten LJ; Hveem K; Njølstad I; Gerhard DS; Tucker M; Hayes RB; Hoover RN; Fraumeni JF; Hunter DJ; Thomas G; Chanock SJ
Hum Mol Genet; 2011 Aug; 20(16):3322-9. PubMed ID: 21576123
[TBL] [Abstract][Full Text] [Related]
10. Association study of type 2 diabetes genetic susceptibility variants and risk of pancreatic cancer: an analysis of PanScan-I data.
Pierce BL; Austin MA; Ahsan H
Cancer Causes Control; 2011 Jun; 22(6):877-83. PubMed ID: 21445555
[TBL] [Abstract][Full Text] [Related]
11. European genetic variants associated with type 2 diabetes in North African Arabs.
Cauchi S; Ezzidi I; El Achhab Y; Mtiraoui N; Chaieb L; Salah D; Nejjari C; Labrune Y; Yengo L; Beury D; Vaxillaire M; Mahjoub T; Chikri M; Froguel P
Diabetes Metab; 2012 Oct; 38(4):316-23. PubMed ID: 22463974
[TBL] [Abstract][Full Text] [Related]
12. Diabetes genes and prostate cancer in the Atherosclerosis Risk in Communities study.
Meyer TE; Boerwinkle E; Morrison AC; Volcik KA; Sanderson M; Coker AL; Pankow JS; Folsom AR
Cancer Epidemiol Biomarkers Prev; 2010 Feb; 19(2):558-65. PubMed ID: 20142250
[TBL] [Abstract][Full Text] [Related]
13. Lack of significant effects of the type 2 diabetes susceptibility loci JAZF1, CDC123/CAMK1D, NOTCH2, ADAMTS9, THADA, and TSPAN8/LGR5 on diabetes and quantitative metabolic traits.
Schleinitz D; Tönjes A; Böttcher Y; Dietrich K; Enigk B; Koriath M; Scholz GH; Blüher M; Zeggini E; McCarthy MI; Kovacs P; Stumvoll M
Horm Metab Res; 2010 Jan; 42(1):14-22. PubMed ID: 19670153
[TBL] [Abstract][Full Text] [Related]
14. Additive interactions between susceptibility single-nucleotide polymorphisms identified in genome-wide association studies and breast cancer risk factors in the Breast and Prostate Cancer Cohort Consortium.
Joshi AD; Lindström S; Hüsing A; Barrdahl M; VanderWeele TJ; Campa D; Canzian F; Gaudet MM; Figueroa JD; Baglietto L; Berg CD; Buring JE; Chanock SJ; Chirlaque MD; Diver WR; Dossus L; Giles GG; Haiman CA; Hankinson SE; Henderson BE; Hoover RN; Hunter DJ; Isaacs C; Kaaks R; Kolonel LN; Krogh V; Le Marchand L; Lee IM; Lund E; McCarty CA; Overvad K; Peeters PH; Riboli E; Schumacher F; Severi G; Stram DO; Sund M; Thun MJ; Travis RC; Trichopoulos D; Willett WC; Zhang S; Ziegler RG; Kraft P;
Am J Epidemiol; 2014 Nov; 180(10):1018-27. PubMed ID: 25255808
[TBL] [Abstract][Full Text] [Related]
15. Transferability and fine mapping of type 2 diabetes loci in African Americans: the Candidate Gene Association Resource Plus Study.
Ng MC; Saxena R; Li J; Palmer ND; Dimitrov L; Xu J; Rasmussen-Torvik LJ; Zmuda JM; Siscovick DS; Patel SR; Crook ED; Sims M; Chen YD; Bertoni AG; Li M; Grant SF; Dupuis J; Meigs JB; Psaty BM; Pankow JS; Langefeld CD; Freedman BI; Rotter JI; Wilson JG; Bowden DW
Diabetes; 2013 Mar; 62(3):965-76. PubMed ID: 23193183
[TBL] [Abstract][Full Text] [Related]
16. Cumulative evidence for relationships between multiple variants of HNF1B and the risk of prostate and endometrial cancers.
Tong Y; Qu Y; Li S; Zhao F; Wang Y; Mu D
BMC Med Genet; 2018 Jul; 19(1):128. PubMed ID: 30053805
[TBL] [Abstract][Full Text] [Related]
17. Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry.
Zhao Z; Wen W; Michailidou K; Bolla MK; Wang Q; Zhang B; Long J; Shu XO; Schmidt MK; Milne RL; García-Closas M; Chang-Claude J; Lindstrom S; Bojesen SE; Ahsan H; Aittomäki K; Andrulis IL; Anton-Culver H; Arndt V; Beckmann MW; Beeghly-Fadiel A; Benitez J; Blomqvist C; Bogdanova NV; Børresen-Dale AL; Brand J; Brauch H; Brenner H; Burwinkel B; Cai Q; Casey G; Chenevix-Trench G; Couch FJ; Cox A; Cross SS; Czene K; Dörk T; Dumont M; Fasching PA; Figueroa J; Flesch-Janys D; Fletcher O; Flyger H; Fostira F; Gammon M; Giles GG; Guénel P; Haiman CA; Hamann U; Harrington P; Hartman M; Hooning MJ; Hopper JL; Jakubowska A; Jasmine F; John EM; Johnson N; Kabisch M; Khan S; Kibriya M; Knight JA; Kosma VM; Kriege M; Kristensen V; Le Marchand L; Lee E; Li J; Lindblom A; Lophatananon A; Luben R; Lubinski J; Malone KE; Mannermaa A; Manoukian S; Margolin S; Marme F; McLean C; Meijers-Heijboer H; Meindl A; Miao H; Muir K; Neuhausen SL; Nevanlinna H; Neven P; Olson JE; Perkins B; Peterlongo P; Phillips KA; Pylkäs K; Rudolph A; Santella R; Sawyer EJ; Schmutzler RK; Schoemaker M; Shah M; Shrubsole M; Southey MC; Swerdlow AJ; Toland AE; Tomlinson I; Torres D; Truong T; Ursin G; Van Der Luijt RB; Verhoef S; Wang-Gohrke S; Whittemore AS; Winqvist R; Pilar Zamora M; Zhao H; Dunning AM; Simard J; Hall P; Kraft P; Pharoah P; Hunter D; Easton DF; Zheng W
Cancer Causes Control; 2016 May; 27(5):679-93. PubMed ID: 27053251
[TBL] [Abstract][Full Text] [Related]
18. Association of indices of liver and adipocyte insulin resistance with 19 confirmed susceptibility loci for type 2 diabetes in 6,733 non-diabetic Finnish men.
Vangipurapu J; Stančáková A; Pihlajamäki J; Kuulasmaa TM; Kuulasmaa T; Paananen J; Kuusisto J; Ferrannini E; Laakso M
Diabetologia; 2011 Mar; 54(3):563-71. PubMed ID: 21153532
[TBL] [Abstract][Full Text] [Related]
19. Impact of nine common type 2 diabetes risk polymorphisms in Asian Indian Sikhs: PPARG2 (Pro12Ala), IGF2BP2, TCF7L2 and FTO variants confer a significant risk.
Sanghera DK; Ortega L; Han S; Singh J; Ralhan SK; Wander GS; Mehra NK; Mulvihill JJ; Ferrell RE; Nath SK; Kamboh MI
BMC Med Genet; 2008 Jul; 9():59. PubMed ID: 18598350
[TBL] [Abstract][Full Text] [Related]
20. Variants in KCNQ1 increase type II diabetes susceptibility in South Asians: a study of 3,310 subjects from India and the US.
Been LF; Ralhan S; Wander GS; Mehra NK; Singh J; Mulvihill JJ; Aston CE; Sanghera DK
BMC Med Genet; 2011 Jan; 12():18. PubMed ID: 21261977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
